Interview
SCmple and TraceLink on supplier collaboration
May 30, 20246 min watch
At a glance
- Why managing supply risk is getting harder for pharmaceutical companies.
- What to prepare for when moving from clinical to commercial supply.
- How SCmple’s integration with TraceLink MINT works.
- How connected planning helps emerging companies work with suppliers and CDMOs.
In this interview
- 01:26Why it is getting harder to manage risk in the pharmaceutical supply chain
- 02:50Advice for companies moving from clinical to commercial supply
- 04:19What makes the partnership with TraceLink and solutions like MINT valuable to clients
- 05:27The challenges TraceLink MINT addresses for supply chain teams
In this conversation with TraceLink, Peter Bigelow, Co-founder and CEO of SCmple, discusses how emerging pharmaceutical companies can manage growing supply chain complexity. He covers why risk is harder to manage today, what companies should prepare for as they move from clinical to commercial supply, and how SCmple and TraceLink MINT work together to connect planning with suppliers, CDMOs, and trading partners.
SCmple is a TraceLink technology partner. View SCmple on TraceLink’s partner page
